CEO: Joseph J. Ciaffoni

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Collegium Pharmaceutical Inc is a specialty pharmaceutical company which is engaged in developing and planning to commercialize abuse-deterrent products through its patented DETERx platform technology.





2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,